Has Gustavo Duarte received payments from drug or device companies?

Yes. Drug and device makers reported $4,071 in general payments to Gustavo Duarte across 144 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Gustavo Duarte did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Gustavo Duarte come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Gustavo Duarte

Internal Medicine · Weston, FLNPI 1003443946

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 144 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 31.3% of the total. 2025 is the largest year on record at $2,298, 4.2 times the $545 reported in 2023.

$4,071in general payments, 2019–2025

Across 144 payments — averaging $28.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$1K
Abbott$912
Boston Scientific$675
Biosense Webster, Inc.$335
Heartflow, Inc.$178
Impulse Dynamics (USA) Inc.$178
plus $519 from 9 others

What the payments were for

Food & beverage$4,071100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic	84	$1,275
Abbott	17	$912
Boston Scientific	10	$675
Biosense Webster, Inc.	7	$335
Heartflow, Inc.	3	$178
Impulse Dynamics (USA) Inc.	1	$178
Amgen	7	$153
Johnson & Johnson	4	$73
Alnylam Pharmaceuticals Inc.	2	$51
Novartis	2	$47
Abiomed	1	$43
Biotronik Inc.	1	$42
Novo Nordisk	2	$42
E.r. Squibb & Sons, L.L.C.	2	$42
AstraZeneca	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,071 in reported general payments places this provider in the 85th percentile of 8,530 internal medicine providers in Florida.

See all internal medicine providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	12	$8,710
Rosuvastatin Calcium	19	$325
ClopidogrelClopidogrel Bisulfate	28	$239
Metoprolol Succinate	15	$152
Carvedilol	14	$147
Pantoprazole Sodium	12	$27

Paid to pharmacies, not to this prescriber.

Other internal medicine in Weston

Haytham ElgammalMiami$2.2M
Keith RubinFort Lauderdale$2M
Michael SensionFort Lauderdale$1M
Quang NguyenOcala$434K
Luis Correa LunaSanford$412K
Michael OleksykFort Myers$365K
Andrew KuykendallTampa$322K
Howard FederoffCoconut Grove$302K
Bianka EperjesiovaGainesville$260K
Julio ConradoFort Myers$247K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →